WHO Director-General Ghebreyesus Says He Considers The Cruise Ship-Linked Hantavirus Outbreak To Be Over

Piper Sandler Maintains Neutral on Amphastar Pharma, Lowers Price Target to $20

Piper Sandler analyst David Amsellem maintains Amphastar Pharma (NASDAQ:AMPH) with a Neutral and lowers the price target from $21 to $20.

Wells Fargo Maintains Equal-Weight on Amphastar Pharma, Raises Price Target to $20

Wells Fargo analyst Benjamin Burnett maintains Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight and raises the price target from $19 to $20.

Amphastar Pharma Q2 Adj. EPS $0.91 Beats $0.62 Estimate, Sales $183.903M Beat $182.055M Estimate

Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.62 by 46.77 percent. This is a 7.06 percent increase over earnings of $0.85 per share from

Shares of cruise companies are trading lower amid an oil price rebound. Expectations for U.S.-Iran negotiations over Strait of Hormuz passage are frozen, with the U.S. threatening major economic pressure on Iran and its trade partners, an approach that may leave energy prices elevated for longer.

Boomers Are Getting Rich and Retiring Early. 1 No-Brainer Stock To Buy Now

Rising stock markets and home prices are giving baby boomers significant disposable income, leading many to retire early. This demographic shift creates investment opportunities for companies targeting affluent older travelers. Viking Holdings, a luxury cruise line focused on adults 55+, is positioned to capitalize on this trend with strong revenue growth and differentiated offerings compared to traditional cruise competitors.

Shares of cruise companies are trading lower amid a rise in oil prices as investors weigh in on a possible impasse in U.S.-Iran Negotiations.